Scientist, Inflammation at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

6+ Years with BS OR 4+ Years with MS OR 0+ Years with PhD/PharmD
Excellent communication skills (both written and verbal) and interpersonal skills
Strong organizational and planning skills
Ability to think critically and creatively
Stay informed of the latest developments in the field
PhD & 2 years of experience preferred
Strong background and hands-on experience in human immunology, inflammatory diseases, or immune modulation strategies preferred
Experience with mouse pre-clinical models of disease preferred (including mouse handling experience and in-vivo techniques)
Demonstrated experience in target discovery, translational research, and drug development preferred
Subject matter expertise in the evaluation of large molecule therapeutics preferred
PhD or equivalent degree and at least 2 years of relevant post-PhD research experience, or drug development experience in immunology/inflammation

Responsibilities

Designing and executing scientific research for the discovery of drug targets, the development of drug candidates, and the identification and validation of drug combinations
Independently designing, conducting, analyzing in vitro and in vivo experiments to support the initiation and/or advancement of drug candidates
Working collaboratively in cross-functional project teams
Proactively evaluating new technologies and developing new assays to enhance understanding of disease mechanisms
Preparing technical study reports, INDs, and patent applications
Contributing to the discovery, research, and development of novel immunotherapeutic agents for inflammatory diseases (e.g., inflammatory bowel disease, rheumatoid arthritis)
Supporting projects across discovery research and into early development on multidisciplinary project teams
Participating as an engaged member of a collaborative department with diverse research interests
Independently designing and executing experiments to advance understanding of disease biology

Skills

immunology

inflammatory diseases

immunotherapeutic agents

discovery research

early development

state-of-the-art technologies

collaborative research

project team leadership

experimental design

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free